Vital Scientific and AMP Medizintechnik Handels Formalize Distribution for Eastern Europe.
NEWTON, Mass.--(BUSINESS WIRE)--Feb. 20, 2001
Novitron International, Inc. (NASDAQ:NOVI) announced today that its Dutch subsidiary, Vital Scientific NV, and AMP Medizintechnik Handels GmbH of Graz, Austria have executed an agreement for the distribution of Vital Scientific instruments in certain Eastern European countries, including Poland and the Balkan States. The territory was formerly covered under an agreement with AVL Medical Instruments AG, Schaffhausen, Switzerland, which was acquired by F. Hoffmann-La Roche AG.
Israel M. Stein MD, President of Novitron International, Inc. stated, "Newly formed, AMP Medizintechnik Handels, is already employing many of the former managers, sales professionals, and service personnel from AVL Medical Instruments AG, who have an intimate knowledge of the clinical laboratory market in Eastern Europe. AMP intends to vigorously address Vital Scientific's significant installed base and to promote and expand sales and service in the territory."
Novitron International, Inc. is a multinational company focusing on scientific instrumentation used in clinical and analytical laboratories and in process monitoring in industry. The Company's Dutch subsidiary, Vital Scientific NV, designs and manufactures scientific instrumentation marketed worldwide through distributors and strategic partnerships. The Company's subsidiary Clinical Data (Australia) Pty. Ltd. distributes diagnostic instruments and assays in the South Pacific. The Company's Dutch subsidiary, NovaChem BV, develops and markets process analyzers.
Except for any historical information contained in this release, the matters discussed herein include forward looking statements, within the meaning of Section 27A of the Securities Act of 1933 (as amended), that involve risk and uncertainties. Actual results could differ materially from those expressed in such statements and readers are referred to the Company's SEC reports and filings.